東駿控股(08383.HK)預計前三財季盈利約1000萬令吉
格隆匯6月29日丨東駿控股(08383.HK)公佈,集團預計截至2021年5月31日止九個月("2021年第三季度")的淨利潤約為1000萬令吉,而比較2020年同期約為80萬令吉。
儘管業務中斷,又礙於馬來西亞以及菲律賓就新型冠狀病毒疫情持續採取了防控措施,我們的管理層仍致力開拓新客户羣,同時與現有客户維持緊密工作關係,儘量減少疫情對集團營運帶來的不利影響。利潤增加主要來自現有客户對創新醫療產品的需求激增,帶動2021年第三季度收入及毛利增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.